Proteomics: Current techniques and potential applications to lung disease

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 287, Issue 1 31-1, 2004, Pages

  Hirsch, Jan ^a   Hansen, Kirk C ^a   Burlingame, Alma L ^a   Matthay, Michael A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Lung; Mass spectrometry; Proteome

Indexed keywords

ANALYTIC METHOD; BIOINFORMATICS; CHROMATOGRAPHY; ELECTROPHORESIS; EXPERIMENTAL DESIGN; HUMAN; LUNG DISEASE; LUNG LAVAGE; MASS SPECTROMETRY; MEDICAL GENETICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CONTENT; PROTEIN MODIFICATION; PROTEIN PROCESSING; PROTEIN PROFILING; PROTEOMICS; QUANTITATIVE ANALYSIS; REVIEW; STAINING;

ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; COMPUTATIONAL BIOLOGY; GENOME, HUMAN; HUMANS; LUNG; LUNG DISEASES; MASS SPECTROMETRY; PROTEOME; PROTEOMICS;

EID: 2942735358     PISSN: 10400605     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajplung.00301.2003     Document Type: Review

References (274)

1. Aberle DR, Wiener-Kronish JP, Webb WR, and Matthay MA. Hydrostatic versus increased permeability pulmonary edema: diagnosis based on radiographic criteria in critically ill patients. Radiology 168: 73-79, 1988.
2. Aebersold R and Goodlett DR. Mass spectrometry in proteomics. Chem Rev 101: 269-295, 2001.
3. Aebersold R and Mann M. Mass spectrometry-based proteomics. Nature 422: 198-207, 2003.
4. Aebersold RH, Leavitt J, Saavedra RA, Hood LE, and Kent SB. Internal amino acid sequence analysis of proteins separated by one- or two-dimensional gel electrophoresis after in situ protease digestion on nitrocellulose. Proc Natl Acad Sci USA 84: 6970-6974, 1987.
5. Ajuh P, Kuster B, Panov K, Zomerdijk JC, Mann M, and Lamond AI. Functional analysis of the human CDC5L complex and identification of its components by mass spectrometry. EMBO J 19: 6569-6581, 2000.
6. Anderson L and Anderson NG. High resolution two-dimensional electrophoresis of human plasma proteins. Proc Natl Acad Sci USA 74: 5421-5425, 1977.
7. Anderson NL and Anderson NG. The human plasma proteome: history, character, and diagnostic prospects. Mol Cell Proteomics 1: 845-867, 2002.
8. Annan RS, Huddleston MJ, Verma R, Deshaies RJ, and Carr SA. A multidimensional electrospray MS-based approach to phosphopeptide mapping. Anal Chem 73: 393-404, 2001.
9. Arnott D, Kishiyama A, Luis EA, Ludlum SG, Marsters JC Jr, and Stults JT. Selective detection of membrane proteins without antibodies: a mass spectrometric version of the Western blot. Mol Cell Proteomics 1: 148-156, 2002.
10. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT, Harris MA, Hill DP, Issel-Tarver L, Kasarskis A, Lewis S, Matese JC, Richardson JE, Ringwald M, Rubin GM, and Sherlock G. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet 25: 25-29, 2000.
11. 2-adrenergic agonists achieve therapeutic levels in the pulmonary edema fluid of ventilated patients with acute respiratory failure. Intensive Care Med 28: 705-711, 2002.
12. Badock V, Steinhusen U, Bommert K, and Otto A. Prefractionation of protein samples for proteome analysis using reversed-phase high-performance liquid chromatography. Electrophoresis 22: 2856-2864, 2001.
13. Balint B, Donnelly LE, Hanazawa T, Kharitonov SA, and Barnes PJ. Increased nitric oxide metabolites in exhaled breath condensate after exposure to tobacco smoke. Thorax 56: 456-461, 2001.
14. Baltimore D. Our genome unveiled. Nature 409: 814-816, 2001.
15. Bauer A and Kuster B. Affinity purification-mass spectrometry. Powerful tools for the characterization of protein complexes. Eur J Biochem 270: 570-578, 2003.
16. Beavis RC and Chait BT. Matrix-assisted laser desorption ionization mass-spectrometry of proteins. Methods Enzymol 270: 519-551, 1996.
17. Bell DY, Haseman JA, Spock A, McLennan G, and Hook GE. Plasma proteins of the bronchoalveolar surface of the lungs of smokers and nonsmokers. Am Rev Respir Dis 124: 72-79, 1981.
18. Bell DY and Hook GE. Pulmonary alveolar proteinosis: analysis of airway and alveolar proteins. Am Rev Respir Dis 119: 979-990, 1979.
19. Berggren K, Chernokalskaya E, Steinberg TH, Kemper C, Lopez MF, Diwu Z, Haugland RP, and Patton WF. Background-free, high sensitivity staining of proteins in one- and two-dimensional sodium dodecyl sulfate-polyacrylamide gels using a luminescent ruthenium complex. Electrophoresis 21: 2509-2521, 2000.
20. Bernhardt J, Buttner K, Scharf C, and Hecker M. Dual channel imaging of two-dimensional electropherograms in Bacillus subtilis. Electrophoresis 20: 2225-2240, 1999.
21. Biemann K. Contributions of mass spectrometry to peptide and protein structure. Biomed Environ Mass Spectrom 16: 99-111, 1988.
22. Biemann K and Scoble HA. Characterization by tandem mass spectrometry of structural modifications in proteins. Science 237: 992-998, 1987.
23. Bier ME and Schwartz JC. Electrospray-ionization quadrupole ion-trap mass spectrometry. In: Electrospray Ionization, edited by Cole RB. New York: Wiley & Sons, 1997, p. 235-289.
24. Bjellqvist B, Pasquali C, Ravier F, Sanchez JC, and Hochstrasser D. A nonlinear wide-range immobilized pH gradient for two-dimensional electrophoresis and its definition in a relevant pH scale. Electrophoresis 14: 1357-1365, 1993.
25. Blackstock WP and Weir MP. Proteomics: quantitative and physical mapping of cellular proteins. Trends Biotechnol 17: 121-127, 1999.
26. Bradley ME, Lambert RW, and Mircheff AK. Isolation and identification of plasma membrane populations. Methods Enzymol 228: 432-448, 1994.
27. Brooks DJ and Fresco JR. Increased frequency of cysteine, tyrosine, and phenylalanine residues since the last universal ancestor. Mol Cell Proteomics 1: 125-131, 2002.
28. Burlingame AL. Characterization of protein glycosylation by mass spectrometry. Curr Opin Biotechnol 7: 4-10, 1996.
29. Burlingame AL, Boyd RK, and Gaskell SJ. Mass spectrometry. Anal Chem 70: 647R-716R, 1998.
30. Caprioli RM, Farmer TB, and Gile J. Molecular imaging of biological samples: localization of peptides and proteins using MALDI-TOF MS. Anal Chem 69: 4751-4760. 1997.
31. Carpenter CT, Price PV, and Christman BW. Exhaled breath condensate isoprostanes are elevated in patients with acute lung injury or ARDS. Chest 114: 1653-1659, 1998.
32. Celis JE and Gromov P. 2D protein electrophoresis: can it be perfected? Curr Opin Biotechnol 10: 16-21, 1999.
33. Celis JE, Ostergaard M, Jensen NA, Gromova I, Rasmussen HH, and Gromov P. Human and mouse proteomic databases: novel resources in the protein universe. FEBS Lett 430: 64-72, 1998.
34. Celis JE, Rasmussen HH, Gromov P, Olsen E, Madsen P, Leffers H, Honore B, Dejgaard K, Vorum H, Kristensen DB, Østergaard M, Haunsø A, Jensen NA, Celis A, Basse B, Lauridsen JB, Ratz GP, Andersen AH, Walbum E, Kjaergaard I, Anderson I, Puype M, Van Damme J, and Vandekerckhove J. The human keratinocyte two-dimensional gel protein database (update 1995): mapping components of signal transduction pathways. Electrophoresis 16: 2177-2240, 1995.
35. Chalkley RJ and Burlingame AL. Identification of GlcNAcylation sites of peptides and α-crystallin using Q-TOF mass spectrometry. J Am Soc Mass Spectrom 12: 1106-1113, 2001.
36. Chang JW, Jeon HB, Lee JH, Yoo JS, Chun JS, Kim JH, and Yoo YJ. Augmented expression of peroxiredoxin I in lung cancer. Biochem Biophys Res Commun 289: 507-512, 2001.
37. Chaurand P and Caprioli RM. Direct profiling and imaging of peptides and proteins from mammalian cells and tissue sections by mass spectrometry. Electrophoresis 23: 3125-3135, 2002.
38. Chaurand P, Schwartz SA, and Caprioli RM. Imaging mass spectrometry: a new tool to investigate the spatial organization of peptides and proteins in mammalian tissue sections. Curr Opin Chem Biol 6: 676-681, 2002.
39. Chaurand P, Stoeckli M, and Caprioli RM. Direct profiling of proteins in biological tissue sections by MALDI mass spectrometry. Anal Chem 71: 5263-5270, 1999.
40. Chen G, Gharib TG, Huang CC, Thomas DG, Shedden KA, Taylor JM, Kardia SL, Misek DE, Giordano TJ, Iannettoni MD, Orringer MB, Hanash SM, and Beer DG. Proteomic analysis of lung adenocarcinoma: identification of a highly expressed set of proteins in tumors. Clin Cancer Res 8: 2298-2305, 2002.
41. Cheng IW, Ware LB, Greene KE, Nuckton TJ, Eisner MD, and Matthay MA. Prognostic value or surfactant proteins A and D in patients with acute lung injury. Crit Care Med 31: 20-27, 2003.
42. Chernushevich IV, Loboda AV, and Thomson BA. An introduction to quadrupole-time-of-flight mass spectrometry. J Mass Spectrom 36: 849-865, 2001.
43. Chesnutt AN, Matthay MA, Tibayan FA, and Clark JG, Early detection of type III procollagen peptide in acute lung injury. Pathogenetic and prognostic significance. Am J Respir Crit Care Med 156: 840-845, 1997.
44. Clauser KR, Baker P, and Burlingame AL. Role of accurate mass measurement (±10 ppm) in protein identification strategies employing MS or MS/MS and database searching. Anal Chem 71: 2871-2882, 1999.
45. Clauser KR, Hall SC, Smith DM, Webb JW, Andrews LE, Tran HM, Epstein LB, and Burlingame AL. Rapid mass spectrometric peptide sequencing and mass matching for characterization of human melanoma proteins isolated by two-dimensional PAGE. Proc Natl Acad Sci USA 92: 5072-5076, 1995.
46. Cohen P. The regulation of protein function by multisite phosphorylation-a 25 year update. Trends Biochem Sci 25: 596-601, 2000.
47. Comisarow MB and Marshall AG. Fourier transform ion cyclotron resonance spectroscopy. Chem Phys Lett 25: 282-283, 1974.
48. Courchesne PL, Luethy R, and Patterson SD. Comparison of in-gel and on-membrane digestion methods at low to sub-pmol level for subsequent peptide and fragment-ion mass analysis using matrix-assisted laser-desorption/ionization mass spectrometry. Electrophoresis 18: 369-381, 1997.
49. Cowley EA, Govindaraju K, Guilbault C, Radzioch D, and Eidelman DH. Airway surface liquid composition in mice. Am J Physiol Lung Cell Mol Physiol 278: L1213-L1220, 2000.
50. Davis IC, Zhu S, Sampson JB, Crow JP, and Matalon S. Inhibition of human surfactant protein A function by oxidation intermediates of nitrite. Free Radic Biol Med 33: 1703-1713, 2002.
51. Dekhuijzen PN, Aben KK, Dekker I, Aarts LP, Wielders PL, van Herwaarden CL, and Bast A. Increased exhalation of hydrogen peroxide in patients with stable and unstable chronic obstructive pulmonary disease. Am J Respir Crit Care Med 154: 813-816, 1996.
52. Dell A and Morris HR. Glycoprotein structure determination by mass spectrometry. Science 291: 2351-2356, 2001.
53. Deutscher MP. Guide to Protein Purification. San Diego, CA: Academic, 1990.
54. Devlin RB and Koren HS. The use of quantitative two-dimensional gel electrophoresis to analyze changes in alveolar macrophage proteins in humans exposed to ozone. Am J Respir Cell Mol Biol 2: 281-288, 1990.
55. Diamandis EP. Point: proteomic patterns in biological fluids: do they represent the future of cancer diagnostics? Clin Chem 49: 1272-1275, 2003.
56. DiFederico EM, Harrison M, and Matthay MA. Pulmonary edema in a woman following fetal surgery. Chest 109: 1114-1117, 1996.
57. Doyle IR, Bersten AD, and Nicholas TE. Surfactant proteins-A and -B are elevated in plasma of patients with acute respiratory failure. Am J Respir Crit Care Med 156: 1217-1229, 1997.
58. Duncan R and McConkey EH. How many proteins ate there in a typical mammalian cell? Clin Chem 28: 749-755, 1982.
59. Eng JK, McCormack AL, and Yates JR. An approach to correlate tandem mass spectral data of peptides with amino acid sequences in a protein database. J Am Soc Mass Spectrom 5: 976-989, 1994.
60. Epstein LB, Smith DM, Matsui NM, Tran HM, Sullivan C, Raineri I, Burlingame AL, Clauser KR, Hall SC, and Andrews LE. Identification of cytokine-regulated proteins in normal and malignant cells by the combination of two-dimensional polyacrylamide gel electrophoresis, mass spectrometry. Edman degradation and immunoblotting and approaches to the analysis of their functional roles. Electrophoresis 17: 1655-1670, 1996.
61. Evans S. Detectors. In: Mass Spectrometry, edited by McCloskey JA. San Diego, CA: Academic, 1990, p. 61-86.
62. Fenn JB, Mann M, Meng CK, Wong SF, and Whitehouse CM. Electrospray ionization for mass spectrometry of large biomolecules. Science 246: 64-71, 1989.
63. Fenyo D and Beavis RC. A method for assessing the statistical significance of mass spectrometry-based protein identifications using general scoring schemes. Anal Chem 75: 768-774, 2003.
64. Fey SJ and Larsen PM. 2D or not 2D. Two-dimensional gel electrophoresis. Curr Opin Chem Biol 5: 26-33, 2001.
65. Ficarro SB, McCleland ML, Stukenberg PT, Burke DJ, Ross MM, Shabanowitz J, Hunt DF, and White FM. Phosphoproteome analysis by mass spectrometry and its application to Saccharomyces cerevisiae. Nat Biotechnol 20: 301-305, 2002.
66. Figeys D. Functional proteomics: mapping protein-protein interactions and pathways. Curr Opin Mol Ther 4: 210-215, 2002.
67. Figeys D. Novel approaches to map protein interactions. Curr Opin Biotechnol 14: 119-125, 2003.
68. Figeys D. Proteomics in 2002: a year of technical development and wide-ranging applications. Anal Chem 75: 2891-2905, 2003.
69. Figeys D, Ducret A, Yates JR III, and Aebersold R. Protein identification by solid phase microextraction-capillary zone electrophoresis- microelectrospray-tandem mass spectrometry. Nat Biotechnol 14: 1579-1583, 1996.
70. Fountoulakis M, Juranville JF, Berndt P, Langen H, and Suter L. Two-dimensional database of mouse liver proteins. An update. Electrophoresis 22: 1747-1763, 2001.
71. Gavin AC, Bosche M, Krause R, Grandi P, Marzioch M, Bauer A, Schultz J, Rick JM, Michon AM, Cruciat CM, Remor M, Hofert C, Schelder M, Brajenovic M, Ruffner H, Merino A, Klein K, Hudak M, Dickson D, Rudi T, Gnau V, Bauch A, Bastuck S, Huhse B, Leutwein C, Heurtier MA, Copley RR, Edelmann A, Querfurth E, Rybin V, Drewes G, Raida M, Bouwmeester T, Bork P, Seraphin B, Kuster B, Neubauer G, and Superti-Furga G. Functional organization of the yeast proteome by systematic analysis of protein complexes. Nature 415: 141-147, 2002.
72. Geiser T, Atabai K, Jarreau PH, Ware LB, Pugin J, and Matthay MA. Pulmonary edema fluid from patients with acute lung injury augments in vitro alveolar epithelial repair by an IL-1β-dependent mechanism. Am J Respir Crit Care Med 163: 1384-1388, 2001.
73. Ghafouri B, Stahlbom B, Tagesson C, and Lindahl M. Newly identified proteins in human nasal lavage fluid from non-smokers and smokers using two-dimensional gel electrophoresis and peptide mass finger-printing. Proteomics 2: 112-120, 2002.
74. Gharbi S, Gaffney P, Yang A, Zvelebil MJ, Cramer R, Waterfield MD, and Timms JF. Evaluation of two-dimensional differential gel electrophoresis for proteomic expression analysis of a model breast cancer cell system. Mol Cell Proteomics 1: 91-98, 2002.
75. Godovac-Zimmermann J and Brown LR. Perspectives for mass spectrometry and functional proteomics. Mass Spectrom Rev 20: 1-57, 2001.
76. Godovac-Zimmermann J, Soskic V, Poznanovic S, and Brianza F. Functional proteomics of signal transduction by membrane receptors. Electrophoresis 20: 952-961, 1999.
77. Gorg A, Obermaier C, Boguth G, Harder A, Scheibe B, Wildgruber R, and Weiss W. The current state of two-dimensional electrophoresis with immobilized pH gradients. Electrophoresis 21: 1037-1053, 2000.
78. Goshe MB and Smith RD. Stable isotope-coded proteomic mass spectrometry. Curr Opin Biotechnol 14: 101-109, 2003.
79. Goshe MB, Veenstra TD, Panisko EA, Conrads TP, Angell NH, and Smith RD. Phosphoprotein isotope-coded affinity tags: application to the enrichment and identification of low-abundance phosphoproteins. Anal Chem 74: 607-616, 2002.
80. Govindaraju K and Lloyd DK. Analysis of small-scale biological compartments by capillary electrophoresis. J Chromatogr B Biomed Sci Appl 745: 127-135, 2000.
81. Griese M, Neumann M, von Bredow T, Schmidt R, and Ratjen F. Surfactant in children with malignancies, immunosuppression, fever and pulmonary infiltrates. Eur Respir J 20: 1284-1291, 2002.
82. 1-protease inhibitor in cystic fibrosis. Electrophoresis 22: 165-171, 2001.
83. Griffin TJ and Aebersold R. Advances in proteome analysis by mass spectrometry. J Biol Chem 276: 45497-45500, 2001.
84. Griffin TJ, Goodlett DR, and Aebersold R. Advances in proteome analysis by mass spectrometry. Curr Opin Biotechnol 12: 607-612, 2001.
85. Griffin TJ, Gygi SP, Rist B, Aebersold R, Loboda A, Jilkine A, Ens W, and Standing KG. Quantitative proteomic analysis using a MALDI quadrupole time-of-flight mass spectrometer. Anal Chem 73: 978-986, 2001.
86. Gygi SP and Aebersold R. Mass spectrometry and proteomics. Curr Opin Chem Biol 4: 489-494, 2000.
87. Gygi SP, Corthals GL, Zhang Y, Rochon Y, and Aebersold R. Evaluation of two-dimensional gel electrophoresis-based proteome analysis technology. Proc Natl Acad Sci USA 97: 9390-9395, 2000.
88. Gygi SP, Rist B, Gerber SA, Turecek F, Gelb MH, and Aebersold R. Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. Nat Biotechnol 17: 994-999, 1999.
89. Gygi SP, Rochon Y, Franza BR, and Aebersold R. Correlation between protein and mRNA abundance in yeast. Mol Cell Biol 19: 1720-1730, 1999.
90. Haebel S, Albrecht T, Sparbier K, Walden P, Korner R, and Steup M. Electrophoresis-related protein modification: alkylation of carboxy residues revealed by mass spectrometry. Electrophoresis 19: 679-686, 1998.
91. Han DK, Eng J, Zhou H, and Aebersold R. Quantitative profiling of differentiation-induced microsomal proteins using isotope-coded affinity tags and mass spectrometry. Nat Biotechnol 19: 946-951, 2001.
92. Hansen KC, Schmitt-Ulms G, Chalkley RJ, Hirsch J, Baldwin MA, and Burlingame AL. Mass spectrometric analysis of protein mixtures at low levels using cleavable 13C-ICAT and multi-dimensional chromatography. Mol Cell Proteomics 2: 299-314, 2003.
93. Haqqani AS, Kelly JF, and Birnboim HC. Selective nitration of histone tyrosine residues in vivo in mutatect tumors. J Biol Chem 277: 3614-3621, 2002.
94. Hart SR, Waterfield MD, Burlingame AL, and Cramer R. Factors governing the solubilization of phosphopeptides retained on ferric NTA IMAC beads and their analysis by MALDI TOFMS. J Am Soc Mass Spectrom 13: 1042-1051, 2002.
95. Hayes RN and Gross ML. Collision-induced dissociation. Methods Enzymol 193: 237-263, 1990.
96. Henig NR, Tonelli MR, Pier MV, Burns JL, and Aitken ML. Sputum induction as a research tool for sampling the airways of subjects with cystic fibrosis. Thorax 56: 306-311, 2001.
97. Henzel WJ, Billeci TM, Stults JT, Wong SC, Grimley C, and Watanabe C. Identifying proteins from two-dimensional gels by molecular mass searching of peptide fragments in protein sequence databases. Proc Natl Acad Sci USA 90: 5011-5015, 1993.
98. Herbert BR, Harry JL, Packer NH, Gooley AA, Pedersen SK, and Williams KL. What place for polyacrylamide in proteomics? Trends Biotechnol 19: S3-S9, 2001.
99. Hermann T, Wersch G, Uhlemann EM, Schmid R, and Burkovski A. Mapping and identification of Corynebacterium glutamicum proteins by two-dimensional gel electrophoresis and microsequencing. Electrophoresis 19: 3217-3221, 1998.
100. Hirsch J, Hansen KC, Chalkley RJ, Frank JA, Fang X, Burlingame AL, and Matthay MA. Proteomic patterns in acute lung injury human pulmonary edema fluid compared to hydrostatic pulmonary edema (Abstract). Am J Respir Crit Care Med. In press.
101. Huang L, Baldwin MA, Maltby DA, Medzihradszky KF, Baker PR, Allen N, Rexach M, Edmondson RD, Campbell J, Juhasz P, Martin SA, Vestal ML, and Burlingame AL. The identification of protein-protein interactions of the nuclear pore complex of Saccharomyces cerevisiae using high throughput matrix-assisted laser desorption ionization time-of-flight tandem mass spectrometry. Mol Cell Proteomics 1: 434-450, 2002.
102. Huber LA. Is proteomics heading in the wrong direction? Nat Rev Mol Cell Biol 4: 74-80, 2003.
103. Hunninghake GW, Gadek JE, Kawanami O, Ferrans VJ, and Crysal RG. Inflammatory and immune processes in the human lung in health and disease. Am J Pathol 97: 149-204, 1979.
104. Husi H, Ward MA, Choudhary JS, Blackstock WP, and Grant SG. Proteomic analysis of NMDA receptor-adhesion protein signaling complexes. Nat Neurosci 3: 661-669, 2000.
105. Ideker T, Thorsson V, Ranish JA, Christmas R, Buhler J, Eng JK, Bumgarner R, Goodlett DR, Aebersold R, and Hood L. Integrated genomic and proteomic analyses of a systematically perturbed metabolic network. Science 292: 929-934, 2001.
106. Issaq HJ. The role of separation science in proteomics research. Electrophoresis 22: 3629-3638 2001.
107. Issaq HJ, Conrads TP, Janini GM, and Veenstra TD. Methods for fractionation, separation and profiling of proteins and peptides. Electrophoresis 23: 3048-3061 2002.
108. Issaq HJ, Veenstra TD, Conrads TP, and Felschow D. The SELDI-TOF MS approach to proteomics: protein profiling and biomarker identification. Biochem Biophys Res Commun 292: 587-592, 2002.
109. James P, Quadroni M, Carafoli E, and Gonnet G. Protein identification in DNA databases by peptide mass fingerprinting. Protein Sci 3: 1347-1350, 1994.
110. Johnson RS, Martin SA, Biemann K, Stults JT, and Watson JT. Novel fragmentation process of peptides by collision-induced decomposition in a tandem mass spectrometer: differentiation of leucine and isoleucine. Anal Chem 59: 2621-2625, 1987.
111. Jones KP. A comparison of albumin and urea as reference markers in bronchoalveolar lavage fluid from patients with ideopathic pulmonary fibrosis. Eur Resp J 3: 152-156, 1990.
112. Jones PD, Hankin R, Simpson J, Gibson PG, and Henry RL. The tolerability, safety, and success of sputum induction and combined hypertonic saline challenge in children. Am J Respir Crit Care Med 164: 1146-1149, 2001.
113. Jonscher KR and Yates JR III. The quadrupole ion trap mass spectrometer-a small solution to a big challenge. Anal Biochem 244: 1-15, 1997.
114. Kallet RH, Alonso JA, Luce JM, and Matthay MA. Exacerbation of acute pulmonary edema during assisted mechanical ventilation using a low-tidal volume, lung-protective ventilator strategy. Chest 116: 1826-1832, 1999.
115. Kanamoto T, Hellman U, Heldin CH, and Souchelnytskyi S. Functional proteomics of transforming growth factor-β1-stimulated Mv1Lu epithelial cells: Rad51 as a target of TGFβ1-dependent regulation of DNA repair. EMBO J 21: 1219-1230, 2002.
116. Karas M and Hillenkamp F. Laser desorption ionization of proteins with molecular masses exceeding 10,000 daltons. Anal Chem 60: 2299-2301, 1988.
117. Karlin S, Brocchieri L, Trent J, Blaisdell BE, and Mrazek J. Heterogeneity of genome and proteome content in bacteria, archaea, and eukaryotes. Theor Popul Biol 61: 367-390, 2002.
118. Kerkhoff C, Klempt M, and Sorg C. Novel insights into structure and function of MRP8 (S100A8) and MRP14 (S100A9). Biochim Biophys Acta 1448: 200-211, 1998.
119. Klose J. Large-gel 2-D electrophoresis. Methods Mol Biol 112: 147-172, 1999.
120. Klose J. Protein mapping by combined isoelectric focusing and electrophoresis of mouse tissues. A novel approach to testing for induced point mutations in mammals, Humangenetik 26: 231-243, 1975.
121. Klose J, Nock C, Herrmann M, Stuhler K, Marcus K, Bluggel M, Krause E, Schalkwyk LC, Rastan S, Brown SD, Bussow K, Himmelbauer H, and Lehrach H. Genetic analysis of the mouse brain proteome. Nat Genet 30: 385-393, 2002.
122. Knight ZA, Schilling B, Row RH, Kenski DM, Gibson BW, and Shokat KM. Phosphospecific proteolysis for mapping sites of protein phosphorylation. Nat Biotechnol 21: 1047-1054, 2003.
123. Kocher T, Allmaier G, and Wilm M. Nanoelectrospray-based detection and sequencing of substoichiometric amounts of phosphopeptides in complex mixtures. J Mass Spectrom 38: 131-137, 2003.
124. Krishna RG and Wold F. Proteins. analysis and design, San Diego, CA: Academic, 1998, p. 121.
125. Krivankova L and Bocek P. Continuous free-flow electrophoresis. Electrophoresis 19: 1064-1074, 1998.
126. 2-macroglobulin in patients with acute lung injury. Am J Physiol Lung Cell Mol Physiol 282: L1092-L1098, 2002.
127. Kuroki Y, Tsutahara S, Shijubo N, Takahashi H, Shiratori M, Hattori A, Honda Y, Abe S, and Akino T. Elevated levels of lung surfactant protein A in sera from patients with idiopathic pulmonary fibrosis and pulmonary alveolar proteinosis. Am Rev Respir Dis 147: 723-729, 1993.
128. Kuster B, Wheeler SF, Hunter AP, Dwek RA, and Harvey DJ. Sequencing of N-linked oligosaccharides directly from protein gels: in-gel deglycosylation followed by matrix-assisted laser desorption/ionization mass spectrometry and normal-phase high-performance liquid chromatography. Anal Biochem 250: 82-101, 1997.
129. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685, 1970.
130. Lame MW, Jones AD, Wilson DW, Dunston SK, and Segall HJ. Protein targets of monocrotaline pyrrole in pulmonary artery endothelial cells. J Biol Chem 275: 29091-29099, 2000.
131. Lang JD, McArdle PJ, O'Reilly PJ, and Matalon S. Oxidant-antioxidant balance in acute lung injury. Chest 122: 314S-320S, 2002.
132. Langen H, Roder D, Juranville JF, and Fountoulakis M. Effect of protein application mode and acrylamide concentration on the resolution of protein spots separated by two-dimensional gel electrophoresis. Electrophoresis 18: 2085-2090, 1997.
133. Le Blanc JC, Hager JW, Ilisiu AM, Hunter C, Zhong F, and Chu I. Unique scanning capabilities of a new hybrid linear ion trap mass spectrometer (Q TRAP) used for high sensitivity proteomics applications. Proteomics 3: 859-869, 2003.
134. Lenz AG, Meyer B, Costabel U, and Maier K. Bronchoalveolar lavage fluid proteins in human lung disease: analysis by two-dimensional electrophoresis. Electrophoresis 14: 242-244, 1993.
135. Lenz AG, Meyer B, Weber H, and Maier K. Two-dimensional electrophoresis of dog bronchoalveolar lavage fluid proteins. Electrophoresis 11: 510-513, 1990.
136. Lesley SA. High-throughput proteomics: protein expression and purification in the postgenomic world. Protein Expr Purif 22: 159-164, 2001.
137. Lindahl M, Ekstrom T, Sorensen J, and Tagesson C. Two dimensional protein patterns of bronchoalveolar lavage fluid from non-smokers, smokers, and subjects exposed to asbestos. Thorax 51: 1028-1035, 1996.
138. Lindahl M, Stahlbom B, Svartz J, and Tagesson C. Protein patterns of human nasal and bronchoalveolar lavage fluids analyzed with two-dimensional gel electrophoresis. Electrophoresis 19: 3222-3229, 1998.
139. Lindahl M, Stahlbom B, and Tagesson C. Identification of a new potential airway irritation marker, palate lung nasal epithelial clone protein, in human nasal lavage fluid with two-dimensional electrophoresis and matrix-assisted laser desorption/ionization-time of flight. Electrophoresis 22: 1795-1800, 2001.
140. Lindahl M, Stahlbom B, and Tagesson C. Newly identified proteins in human nasal and bronchoalveolar lavage fluids: potential biomedical and clinical applications. Electrophoresis 20: 3670-3676, 1999.
141. Lindahl M, Stahlbom B, and Tagesson C. Two-dimensional gel electrophoresis of nasal and bronchoalveolar lavage fluids after occupational exposure. Electrophoresis 16: 1199-1204, 1995.
142. Lindahl M, Svartz J, and Tagesson C. Demonstration of different forms of the anti-inflammatory proteins lipocortin-1 and Clara cell protein-16 in human nasal and bronchoalveolar lavage fluids. Electrophoresis 20: 881-890, 1999.
143. Link AJ, Eng J, Schieltz DM, Carmack E, Mize GJ, Morris DR, Garvik BM, and Yates JR III. Direct analysis of protein complexes using mass spectrometry. Nat Biotechnol 17: 676-682, 1999.
144. Lipton MS, Pasa-Tolic L, Anderson GA, Anderson DJ, Auberry DL, Battista JR, Daly MJ, Fredrickson J, Hixson KK, Kostandarithes H, Masselon C, Markillie LM, Moore RJ, Romine MF, Shen Y, Stritmatter E, Tolic N, Udseth HR, Venkateswaran A, Wong KK, Zhao R, and Smith RD. Global analysis of the Deinococcus radiodurans proteome by using accurate mass tags. Proc Natl Acad Sci USA 99: 11049-11054, 2002.
145. Malmstrom J, Larsen K, Hansson L, Lofdahl CG, Norregard-Jensen O, Marko-Varga G, and Westergren-Thorsson G. Proteoglycan and proteome profiling of central human pulmonary fibrotic tissue utilizing miniaturized sample preparation: a feasibility study. Proteomics 2: 394-404, 2002.
146. Manabe T. Capillary electrophoresis of proteins for proteomic studies. Electrophoresis 20: 3116-3121, 1999.
147. Manabe T. Combination of electrophoretic techniques for comprehensive analysis of complex protein systems. Electrophoresis 21: 1116-1122, 2000.
148. Manabe T, Mizuma H, and Watanabe K. A nondenaturing protein map of human plasma proteins correlated with a denaturing polypeptide map combining techniques of micro two-dimensional gel electrophoresis. Electrophoresis 20: 830-835, 1999.
149. Mann M, Hendrickson RC, and Pandey A. Analysis of proteins and proteomes by mass spectrometry. Annu Rev Biochem 70: 437-473, 2001.
150. Mann M, Hojrup P, and Roepstorff P. Use of mass spectrometric molecular weight information to identify proteins in sequence databases. Biol Mass Spectrom 22: 338-345, 1993.
151. Mann M and Jensen ON. Proteomic analysis of post-translational modifications. Nat Biotechnol 21: 255-261, 2003.
152. Mann M, Ong SE, Gronborg M, Steen H, Jensen ON, and Pandey A. Analysis of protein phosphorylation using mass spectrometry: deciphering the phosphoproteome. Trends Biotechnol 20: 261-268, 2002.
153. Manning G, Whyte DB, Martinez R, Hunter T, and Sudarsanam S. The protein kinase complement of the human genome. Science 298: 1912-1934, 2002.
154. March RE and Todd JFJ. Practical Aspects of Ion Trap Mass Spectrometry Boca Raton, FL: CRC. 1995.
155. Marshall AG, Hendrickson CL, and Jackson GS. Fourier transform ion cyclotron resonance mass spectrometry: a primer. Mass Spectrom Rev 17: 1-35, 1998.
156. Marshall AG, Hendrickson CL, and Shi SD. Scaling MS plateaus with high-resolution FT-1CRMS. Anal Chem 74: 252A-259A, 2002.
157. Matthay MA and Wiener-Kronish JP. Intact epithelial barrier function is critical for the resolution of alveolar edema in humans. Am Rev Respir Dis 142: 1250-1257, 1990.
158. McLachlin DT and Chait BT. Analysis of phosphorylated proteins and peptides by mass spectrometry. Curr Opin Chem Biol 5: 591-602, 2001.
159. McLuckey SA, Van Berkel GJ, Goeringer DE, and Glish GL. Ion trap mass spectrometry. Using high-pressure ionization. Anal Chem 66: 737A-743A, 1994.
160. Medzihradszky KF and Burlingame AL. The advantages and versatility of a high-energy collision-induced dissociation-based strategy for the sequence and structural determination of proteins. Methods Comp Methods Enzymol 6: 284-303, 1994.
161. Medzihradszky KF, Campbell JM, Baldwin MA, Falick AM, Juhasz P, Vestal ML, and Burlingame AL. The characteristics of peptide collision-induced dissociation using a high-performance MALDI-TOF/TOF tandem mass spectrometer. Anal Chem 72: 552-558, 2000.
162. Medzihradszky KF, Leffler H, Baldwin MA, and Burlingame AL. Protein identification by in-gel digestion, high-performance liquid chromatography, and mass spectrometry: peptide analysis by complementary ionization techniques. J Am Soc Mass Spectrom 12: 215-221, 2001.
163. Merchant M and Weinberger SR. Recent advancements in surface-enhanced laser desorption/ionization-time of flight-mass spectrometry. Electrophoresis 21: 1164-1177, 2000.
164. Miklos GL and Maleszka R. Protein functions and biological contexts. Proteomics 1: 169-178, 2001.
165. Miller EJ, Cohen AB, and Matthay MA. Increased interleukin-8 concentrations in the pulmonary edema fluid of patients with acute respiratory distress syndrome from sepsis. Crit Care Med 24: 1448-1454, 1996.
166. Monribot-Espagne C and Boucherie H. Differential gel exposure, a new methodology for the two-dimensional comparison of protein samples. Proteomics 2: 229-240, 2002.
167. Montuschi P, Collins JV, Ciabattoni G, Lazzeri N, Corradi M, Kharitonov SA, and Barnes PJ. Exhaled 8-isoprostane as an in vivo biomarker of lung oxidative stress in patients with COPD and healthy smokers. Am J Respir Crit Care Med 162: 1175-1177, 2000.
168. Montuschi P, Corradi M, Ciabattoni G, Nightingale J, Kharitonov SA, and Barnes PJ. Increased 8-isoprostane, a marker of oxidative stress, in exhaled condensate of asthma patients. Am J Respir Crit Care Med 160: 216-220, 1999.
169. Montuschi P, Kharitonov SA, and Barnes PJ. Exhaled carbon monoxide and nitric oxide in COPD. Chest 120: 496-501, 2001.
170. Morre DJ, Reust T, and Morre DM. Plasma and internal membranes from cultured mammalian cells. Methods Enzymol 228: 448-450, 1994.
171. Neuhoff V, Arold N, Taube D, and Ehrhardt W. Improved staining of proteins in polyacrylamide gels including isoelectric focusing gels with clear background at nanogram sensitivity using Coomassie brilliant blue G-250 and R-250. Electrophoresis 9: 255-262, 1988.
172. Neumann M, von Bredow C, Ratjen F, and Griese M. Bronchoalveolar lavage protein patterns in children with malignancies, immunosuppression, fever and pulmonary infiltrates. Proteomics 2: 683-689, 2002.
173. Newman V, Gonzalez RF, Matthay MA, and Dobbs LG. A novel alveolar type I cell-specific biochemical marker of human acute lung injury. Am J Respir Crit Care Med 161: 990-995, 2000.
174. Nguyen A and Yaffe MB. Proteomics and systems biology approaches to signal transduction in sepsis. Crit Care Med 31: S1-S6, 2003.
175. Noel-Georis I, Bernard A, Falmagne P, and Wattiez R. Database of bronchoalveolar lavage fluid proteins. J Chromatogr B Analyt Technol Biomed Life Sci 771: 221-236, 2002.
176. Oda Y, Nagasu T, and Chait BT. Enrichment analysis of phosphorylated proteins as a tool for probing the phosphoproteome. Nat Biotechnol 19: 379-382, 2001.
177. O'Farrell PH. High resolution two-dimensional electrophoresis of proteins. J Biol Chem 250: 4007-4021, 1975.
178. Olivieri D, D'Ippolito R, and Chetta A. Induced sputum: diagnostic value in interstitial lung disease. Curr Opin Pulm Med 6: 411-414, 2000.
179. Ostrowski LE, Blackburn K, Radde KM, Moyer MB, Schlatzer DM, Moseley A, and Boucher RC. A proteomic analysis of human cilia: identification of novel components. Mol Cell Proteomics 1: 451-465, 2002.
180. Pappin D, Hojrup P, and Bleasby A. Rapid identification of proteins by peptide-mass fingerprinting. Curr Biol 3: 327-332, 1993.
181. Park J, Hill MM, Hess D, Brazil DP, Hofsteenge J, and Hemmings BA. Identification of tyrosine phosphorylation sites on 3-phosphoinositide-dependent protein kinase-1 and their role in regulating kinase activity. J Biol Chem 276: 37459-37471, 2001.
182. Patterson SD. Data analysis-the Achilles heel of proteomics. Nat Biotechnol 21: 221-222, 2003.
183. Patton WF. Detection technologies in proteome analysis. J Chromatogr B Analyt Technol Biomed Life Sci 771: 3-31, 2002.
184. Patton WF. A thousand points of light: the application of fluorescence detection technologies to two-dimensional gel electrophoresis and proteomics. Electrophoresis 21: 1123-1144, 2000.
185. Patton WF, Schulenberg B, and Steinberg TH. Two-dimensional gel electrophoresis: better than a poke in the ICAT? Curr Opin Biotechnol 13: 321-328, 2002.
186. Paul W and Steinwedel H. A new mass spectrometer without magnetic field. Z Naturforsch A 8: 448-450, 1953.
187. Paulsen IT, Sliwinski MK, Nelissen B, Goffeau A, and Saier MH Jr. Unified inventory of established and putative transporters encoded within the complete genome of Saccharomyces cerevisiae. FEBS Lett 430: 116-125, 1998.
188. Paweletz CP, Trock B, Pennanen M, Tsangaris T, Magnant C, Liotta LA, and Petricoin EF III. Proteomic patterns of nipple aspirate fluids obtained by SELDI-TOF: potential for new biomarkers to aid in the diagnosis of breast cancer. Dis Markers 17: 301-307, 2001.
189. Pawson T and Nash P. Assembly of cell regulatory systems through protein interaction domains. Science 300: 445-452, 2003.
190. Peng J and Gygi SP. Proteomics: the move to mixtures. J Mass Spectrom 36: 1083-1091, 2001.
191. Perkins DN, Pappin DJ, Creasy DM, and Cottrell JS. Probability-based protein identification by searching sequence databases using mass spectrometry data. Electrophoresis 20: 3551-3567, 1999.
192. Petricoin E III and Liotta LA. Counterpoint: the vision for a new diagnostic paradigm. Clin Chem 49: 1276-1278, 2003.
193. Pieper R, Gatlin CL, Makusky AJ, Russo PS, Schatz CR, Miller SS, Su Q, McGrath AM, Estock MA, Parmar PP, Zhao M, Huang ST, Zhou J, Wang F, Esquer-Blasco R, Anderson NL, Taylor J, and Steiner S. The human serum proteome: display of nearly 3700 chromatographically separated protein spots on two-dimensional electrophoresis gels and identification of 325 distinct proteins. Proteomics 3: 1345-1364, 2003.
194. Poly WJ. Nongenetic variation, genetic-environmental interactions and altered gene expression. III. Posttranslational modifications. Camp Biochem Physiol A 118: 551-572, 1997.
195. Posewitz MC and Tempst P. Immobilized gallium(III) affinity chromatography of phosphopeptides. Anal Chem 71: 2883-2892, 1999.
196. Predic J, Soskic V, Bradley D, and Godovac-Zimmermann J. Monitoring of gene expression by functional proteomics: response of human lung fibroblast cells to stimulation by endothelin-1. Biochemistry 41: 1070-1078, 2002.
197. Pugin J, Verghese G, Widmer MC, and Matthay MA. The alveolar space is the site of intense inflammatory and profibrotic reactions in the early phase of acute respiratory distress syndrome. Crit Care Med 27: 304-312, 1999.
198. Rabilloud T. A comparison between low background silver diammine and silver nitrate protein stains. Electrophoresis 13: 429-439, 1992.
199. Rabilloud T. Mechanisms of protein silver staining in polyacrylamide gels: a 10-year synthesis. Electrophoresis 11: 785-794, 1990.
200. Rabilloud T. Two-dimensional gel electrophoresis in proteomics: old, old fashioned, but it still climbs up the mountains. Proteomics 2: 3-10, 2002.
201. Rabilloud T, Adessi C, Giraudel A, and Lunardi J. Improvement of the solubilization of proteins in two-dimensional electrophoresis with immobilized pH gradients. Electrophoresis 19: 307-316, 1997.
202. Rappsilber J and Mann M. What does it mean to identify a protein in proteomics? Trends Biochem Sci 27: 74-78, 2002.
203. Rennard SI. Estimation of volume of epithelial lining fluid by lavage using urea as marker of dilution. J Appl Physiol 60: 532-538, 1986.
204. Rigaut G, Shevchenko A, Rutz B, Wilm M, Mann M, and Seraphin B. A generic protein purification method for protein complex characterization and proteome exploration. Nat Biotechnol 17: 1030-1032, 1999.
205. Roepstorff P and Fohlman J. Proposal for a common nomenclature for sequence ions in mass spectra of peptides. Biomed Mass Spectrom 11: 601, 1984.
206. Roth J. Protein N-glycosylation along the secretory pathway: relationship to organelle topography and function, protein quality control, and cell interactions. Chem Rev 102: 285-303, 2002.
207. Sabounchi-Schutt F, Astrom J, Eklund A, Grunewald J, and Bjellqvist B. Detection and identification of human bronchoalveolar lavage proteins using narrow-range immobilized pH gradient DryStrip and the paper bridge sample application method. Electrophoresis 22: 1851-1860, 2001.
208. Sabounchi-Schutt F, Astrom J, Ollsson I, Eklund A, Grunewald J, and Bjellqvist B. An immobiline DryStrip application method enabling high-capacity two-dimensional gel electrophoresis. Electrophoresis 21: 3649-3656, 2000.
209. Scanlin TF and Glick MC. Terminal glycosylation in cystic fibrosis. Biochim Biophys Acta 1455: 241-253, 1999.
210. Scheideler L, Manke HG, Schwulera U, Inacker O, and Hammerle H. Detection of nonvolatile macromolecules in breath. A possible diagnostic tool? Am Rev Respir Dis 148: 778-784, 1993.
211. Scheler C, Lamer S, Pan Z, Li XP, Salnikow J, and Jungblut P. Peptide mass fingerprint sequence coverage from differently stained proteins on two-dimensional electrophoresis patterns by matrix assisted laser desorption/ionization-mass spectrometry (MALDI-MS). Electrophoresis 19: 918-927, 1998.
212. Schmitt-Ulms G, Legname G, Baldwin MA, Ball HL, Bradon N, Bosque PJ, Crossin KL, Edelman GM, DeArmond SJ, Cohen FE, and Prusiner SB. Binding of neural cell adhesion molecules (N-CAMs) to the cellular prion protein. J Mol Biol 314: 1209-1225, 2001.
213. Sellers TA and Yates JR. Review of proteomics with applications to genetic epidemiology. Genet Epidemiol 24: 83-98, 2003.
214. Shen Y, Berger SJ, Anderson GA, and Smith RD. High-efficiency capillary isoelectric focusing of peptides. Anal Chem 72: 2154-2159, 2000.
215. Shen Y, Zhao R, Berger SJ, Anderson GA, Rodriguez N, and Smith RD. High-efficiency nanoscale liquid chromatography coupled on-line with mass spectrometry using nanoelectrospray ionization for proteomics. Anal Chem 74: 4235-4249, 2002.
216. Shevchenko A, Jensen ON, Podtelejnikov AV, Sagliocco F, Wilm M, Vorm O, Mortensen P, Boucherie H, and Mann M. Linking genome and proteome by mass spectrometry: large-scale identification of yeast proteins from two dimensional gels. Proc Natl Acad Sci USA 93: 14440-14445, 1996.
217. Shevchenko A, Loboda A, Ens W, and Standing KG. MALDI quadrupole time-of-flight mass spectrometry: a powerful tool for proteomic research. Anal Chem 72: 2132-2141, 2000.
218. Shevchenko A, Wilm M, Vorm O, and Mann M. Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal Chem 68: 850-858, 1996.
219. Shiio Y, Donohoe S, Yi EC, Goodlett DR, Aebersold R, and Eisenman RN. Quantitative proteomic analysis of Myc oncoprotein function. EMBO J 21: 5088-5096, 2002.
220. Shou W, Verma R, Annan RS, Huddleston MJ, Chen SL, Carr SA, and Deshaies RJ. Mapping phosphorylation sites in proteins by mass spectrometry. Methods Enzymol 351: 279-296, 2002.
221. Smith WS and Matthay MA. Evidence for a hydrostatic mechanism in human neurogenic pulmonary edema. Chest 111: 1326-1333, 1997.
222. Smolka M, Zhou H, and Aebersold R. Quantitative protein profiling using two-dimensional gel electrophoresis, isotope-coded affinity tag labeling, and mass spectrometry. Mol Cell Proteomics 1: 19-29, 2002.
223. Smolka MB, Zhou H, Purkayastha S, and Aebersold R. Optimization of the isotope-coded affinity tag-labeling procedure for quantitative proteome analysis. Anal Biochem 297: 25-31, 2001.
224. Song Y, Fukuda N, Bai C, Ma T, Matthay MA, and Verkman AS. Role of aquaporins in alveolar fluid clearance in neonatal and adult lung, and in oedema formation following acute lung injury: studies in transgenic aquaporin null mice. J Physiol 525: 771-779, 2000.
225. Spanevello A, Migliori GB, Satta A, Neri M, and Ind PW. Sputum induction: a method to assess airway inflammation in asthma. Monaldi Arch Chest Dis 50: 208-210, 1995.
226. Spiro RG. Protein glycosylation: nature, distribution, enzymatic formation, and disease implications of glycopeptide bonds. Glycobiology 12: 43R-56R, 2002.
227. Srinivas PR, Verma M, Zhao Y, and Srivastava S. Proteomics for cancer biomarker discovery. Clin Chem 48: 1160-1169, 2002.
228. Steen H, Kuster B, Fernandez M, Pandey A, and Mann M. Detection of tyrosine phosphorylated peptides by precursor ion scanning quadrupole TOF mass spectrometry in positive ion mode, Anal Chem 73: 1440-1448, 2001.
229. Steinberg TH, Chernokalskaya E, Berggren K, Lopez MF, Diwu Z, Haugland RP, and Patton WF. Ultrasensitive fluorescence protein detection in isoelectric focusing gels using a ruthenium metal chelate stain, Electrophoresis 21: 486-496, 2000.
230. Steinberg TH, Lauber WM, Berggren K, Kemper C, Yue S, and Patton WF. Fluorescence detection of proteins in sodium dodecyl sulfate-polyacrylamide gels using environmentally benign, nonfixative, saline solution. Electrophoresis 21: 497-508, 2000.
231. Stimson E, Hope J, Chong A, and Burlingame AL. Site-specific characterization of the N-linked glycans of murine prion protein by high-performance liquid chromatography/electrospray mass spectrometry and exoglycosidase digestions. Biochemistry 38: 4885-4895, 1999.
232. Stoeckli M, Chaurand P, Hallahan DE, and Caprioli RM. Imaging mass spectrometry: a new technology for the analysis of protein expression in mammalian tissues. Nat Med 7: 493-496, 2001.
233. Strohman R. Epigenesis: the missing beat in biotechnology? Biotechnology 12: 156-164, 1994.
234. Strong JC and Frey DD. Experimental and numerical studies of the chromatofocusing of dilute proteins using retained pH gradients formed on a strong-base anion-exchange column. J Chromatogr A 769: 129-143, 1997.
235. Switzer RC III, Merril CR, and Shifrin S. A highly sensitive silver stain for detecting proteins and peptides in polyacrylamide gels. Anal Biochem 98: 231-237, 1979.
236. Taylor J, Anderson NL, Scandora AE Jr, Willard KE, and Anderson NG. Design and implementation of a prototype human protein index. Clin Chem 28: 861-866, 1982.
237. Thompson AJ, Hart SR, Franz C, Barnouin K, Ridley A, and Cramer R. Characterization of protein phosphorylation by mass spectrometry using immobilized metal ion affinity chromatography with on-resin β-elimination and Michael addition. Anal Chem 75: 3232-3243, 2003.
238. Tonge R, Shaw J, Middleton B, Rowlinson R, Rayner S, Young J, Pognan F, Hawkins E, Currie I, and Davison M. Validation and development of fluorescence two-dimensional differential gel electrophoresis proteomics technology. Proteomics 1: 377-396, 2001.
239. Tyers M and Mann M. From genomics to proteomics. Nature 422: 193-197, 2003.
240. Unlu M, Morgan ME, and Minden JS. Difference gel electrophoresis: a single gel method for detecting changes in protein extracts. Electrophoresis 18: 2071-2077, 1997.
241. Uy R and Wold F. Posttranslational covalent modification of proteins. Science 198: 890-896, 1977.
242. Venter JC, Adams MD, Myers EW, Li PW, Mural RJ, Sutton GG, Smith HO, Yandell M, Evans CA, Holt RA, Gocayne JD, Amanatides P, Ballew RM, Huson DH, Wortman JR, Zhang Q, Kodira CD, Zheng XH, Chen L, Skupski M, Subramanian G, Thomas PD, Zhang J, Gabor Miklos GL, Nelson C, Broder S, Clark AG, Nadeau J, McKusick VA, Zinder N, Levine AJ, Roberts RJ, Simon M, Slayman C, Hunkapiller M, Bolanos R, Delcher A, Dew I, Fasulo D, Flanigan M, Florea L, Halpern A, Hannenhalli S, Kravitz S, Levy S, Mobarry C, Reinert K, Remington K, Abu-Threideh J, Beasley E, Biddick K, Bonazzi V, Brandon R, Cargill M, Chandramouliswaran I, Charlab R, Chaturvedi K, Deng Z, Di Francesco V, Dunn P, Eilbeck K, Evangelista C, Gabrielian AE, Gan W, Ge W, Gong F, Gu Z, Guan P, Heiman TJ, Higgins ME, Ji RR, Ke Z, Ketchum KA, Lai Z, Lei Y, Li Z, Li J, Liang Y, Lin X, Lu F, Merkulov GV, Milshina N, Moore HM, Naik AK, Narayan VA, Neelam B, Nusskern D, Rusch DB, Salzberg S, Shao W, Shue B, Sun J, Wang Z, Wang A, Wang X, Wang J, Wei M, Wides R, Xiao C, Yan C, Yao A, Ye J, Zhan M, Zhang W, Zhang H, Zhao Q, Zheng L, Zhong F, Zhong W, Zhu S, Zhao S, Gilbert D, Baumhueter S, Spier G, Carter C, Cravchik A, Woodage T, Ali F, An H, Awe A, Baldwin D, Baden H, Barnstead M, Barrow I, Beeson K, Busam D, Carver A, Center A, Cheng ML, Curry L, Danaher S, Davenport L, Desilets R, Dietz S, Dodson K, Doup L, Ferriera S, Garg N, Gluecksmann A, Hart B, Haynes J, Haynes C, Heiner C, Hladun S, Hostin D, Houck J, Howland T, Ibegwam C, Johnson J, Kalush F, Kline L, Koduru S, Love A, Mann F, May D, McCawley S, McIntosh T, McMullen I, Moy M, Moy L, Murphy B, Nelson K, Pfannkoch C, Pratts E, Puri V, Qureshi H, Reardon M, Rodriguez R, Rogers YH, Romblad D, Ruhfel B, Scott R, Sitter C, Smallwood M, Stewart E, Strong R, Suh E, Thomas R, Tint NN, Tse S, Vech C, Wang G, Wetter J, Williams S, Williams M, Windsor S, Winn-Deen E, Wolfe K, Zaveri J, Zaveri K, Abril JF, Guigo R, Campbell MJ, Sjolander KV, Karlak B, Kejariwal A, Mi H, Lazareva B, Hatton T, Narechania A, Diemer K, Muruganujan A, Guo N, Sato S, Bafna V, Istrail S, Lippert R, Schwartz R, Walenz B, Yooseph S, Allen D, Basu A, Baxendale J, Blick L, Caminha M, Carnes-Stine J, Caulk P, Chiang YH, Coyne M, Dahlke C, Mays A, Dombroski M, Donnelly M, Ely D, Esparham S, Fosler C, Gire H, Glanowski S, Glasser K, Glodek A, Gorokhov M, Graham K, Gropman B, Harris M, Heil J, Henderson S, Hoover J, Jennings D, Jordan C, Jordan J, Kasha J, Kagan L, Kraft C, Levitsky A, Lewis M, Liu X, Lopez J, Ma D, Majoros W, McDaniel J, Murphy S, Newman M, Nguyen T, Nguyen N, Nodell M, Pan S, Peck J, Peterson M, Rowe W, Sanders R, Scott J, Simpson M, Smith T, Sprague A, Stockwell T, Turner R, Venter E, Wang M, Wen M, Wu D, Wu M, Xia A, Zandieh A, and Zhu X. The sequence of the human genome. Science 291: 1304-1351, 2001.
243. Verghese GM, McCormick-Shannon K, Mason RJ, and Matthay MA. Hepatocyte growth factor and keratinocyte growth factor in the pulmonary edema fluid of patients with acute lung injury. Biologic and clinical significance. Am J Respir Crit Care Med 158: 386-394, 1998.
244. Vihinen M. Bioinformatics in proteomics. Biomol Eng 18: 241-248, 2001.
245. Von Bredow C, Birrer P, and Griese M. Surfactant protein A and other bronchoalveolar lavage fluid proteins are altered in cystic fibrosis. Eur Respir J 17: 716-722, 2001.
246. Washburn MP, Ulaszek R, Deciu C, Schieltz DM, and Yates JR III. Analysis of quantitative proteomic data generated via multidimensional protein identification technology. Anal Chem 74: 1650-1657, 2002.
247. Washburn MP, Wolters D, and Yates JR III. Large-scale analysis of the yeast proteome by multidimensional protein identification technology. Nat Biotechnol 19: 242-247, 2001.
248. Watarai H, Inagaki Y, Kubota N, Fuju K, Nagafune J, Yamaguchi Y, and Kadoya T. Proteomic approach to the identification of cell membrane proteins. Electrophoresis 21: 460-464, 2000.
249. Wattiez R, Hermans C, Bernard A, Lesur O, and Falmagne P. Human bronchoalveolar lavage fluid: two-dimensional gel electrophoresis, amino acid microsequencing and identification of major proteins. Electrophoresis 20: 1634-1645, 1999.
250. Wattiez R, Hermans C, Cruyt C, Bernard A, and Falmagne P. Human bronchoalveolar lavage fluid protein two-dimensional database: study of interstitial lung diseases. Electrophoresis 21: 2703-2712, 2000.
251. Westergren-Thorsson G, Malmstrom J, and Marko-Varga G. Proteomics-the protein expression technology to study connective tissue biology. J Pharm Biomed Anal 24: 815-824, 2001.
252. Wilkins MR, Gasteiger E, Gooley AA, Herbert BR, Molloy MP, Binz PA, Ou K, Sanchez JC, Bairoch A, Williams KL, and Hochstrasser DF. High-throughput mass spectrometric discovery of protein post-translational modifications. J Mol Biol 289: 645-657, 1999.
253. Wilkins MR, Sanchez JC, Gooley AA, Appel RD, Humphery-Smith I, Hochstrasser DF, and Williams KL. Progress with proteome projects: why all proteins expressed by a genome should be identified and how to do it. Biotechnol Genet Eng Rev 13: 19-50, 1996.
254. Witzmann FA, Bauer MD, Fieno AM, Grant RA, Keough TW, Kornguth SE, Lacey MP, Siegel FL, Sun Y, Wright LS, Young RS, and Witten ML. Proteomic analysis of simulated occupational jet fuel exposure in the lung. Electrophoresis 20: 3659-3669, 1999.
255. Wold F. In vivo chemical modification of proteins (post-translational modification). Annu Rev Biochem 50: 783-814, 1981.
256. Wold F and Moldave K. A short stroll through the posttranslational zoo. Methods Enzymol 107: xiii-xvi, 1984.
257. Wolters DA, Washburn MP, and Yates JR III. An automated multidimensional protein identification technology for shotgun proteomics. Anal Chem 73: 5683-5690, 2001.
258. Wu CC and MacCoss MJ. Shotgun proteomics: tools for the analysis of complex biological systems. Curr Opin Mol Ther 4: 242-250, 2002.
259. Xhou W, Merrick BA, Khaledi MG, and Tomer KB. Detection and sequencing of phosphopeptides affinity bound to immobilized metal ion beads by matrix-assisted laser desorption/ionization mass spectrometry. J Am Soc Mass Spectrom 11: 273-282, 2000.
260. Yan F, Sreekumar A, Laxman B, Chinnaiyan AM, Lubman DM, and Barder TJ. Protein microarrays using liquid phase fractionation of cell lysates. Proteomics 3: 1228-1235, 2003.
261. Yan F, Subramanian B, Nakeff A, Barder TJ, Parus SJ, and Lubman DM. A comparison of drug-treated and untreated HCT-116 human colon adenocarcinoma cells using a 2-D liquid separation mapping method based upon chromatofocusing PI fractionation. Anal Chem 75: 2299-2308, 2003.
262. Yanagida M. Functional proteomics: current achievements. J Chromatogr B Analyt Technol Biomed Life Sci 771: 89-106, 2002.
263. Yanagisawa K, Shyr Y, Xu BJ, Massion PP, Larsen PH, White BC, Roberts JR, Edgerton M, Gonzalez A, Nadaf S, Moore JH, Caprioli RM, and Carbone DP. Proteomic patterns of tumour subsets in non-small-cell lung cancer. Lancet 362: 433-439, 2003.
264. Yates JR III, Mass spectrometry. From genomics to proteomics. Trends Genet 16: 5-8, 2000.
265. Yates JR III, Eng JK, and McCormack AL. Mining genomes: correlating tandem mass spectra of modified and unmodified peptides to sequences in nucleotide databases. Anal Chem 67: 3202-3210, 1995.
266. Yates JR III, Speicher S, Griffin PR, and Hunkapiller T. Peptide mass maps: a highly informative approach to protein identification. Anal Biochem 214: 397-408, 1993.
267. Zappacosta F, Huddleston MJ, Karcher RL, Gelfand VI, Carr SA, and Annan RS. Improved sensitivity for phosphopeptide mapping using capillary colunm HPLC and microionspray mass spectrometry: comparative phosphorylation site mapping from gel-derived proteins. Anal Chem 74: 3221-3231, 2002.
268. Zhang H, Li XJ, Martin DB, and Aebersold R. Identification and quantification of N-linked glycoproteins using hydrazide chemistry, stable isotope labeling and mass spectrometry. Nat Biotechnol 21: 660-666, 2003.
269. Zhang L, Yu W, He T, Yu J, Caffrey RE, Dalmasso EA, Fu S, Pham T, Mei J, Ho JJ, Zhang W, Lopez P, and Ho DD. Contribution of human α-defensin 1, 2, and 3 to the anti-HIV-1 activity of CD8 antiviral factor. Science 298: 995-1000, 2002.
270. Zhang R, Sioma CS, Wang S, and Regnier FE. Fractionation of isotopically labeled peptides in quantitative proteomics. Anal Chem 73: 5142-5149, 2001.
271. Zhang W and Chait BT. ProFound: an expert system for protein identification using mass spectrometric peptide mapping information. Anal Chem 72: 2482-2489, 2000.
272. Zhou H, Watts JD, and Aebersold R. A systematic approach to the analysis of protein phosphorylation, Nat Biotechnol 19: 375-378, 2001.
273. Zhu S, Ware LB, Geiser T, Matthay MA, and Matalon S. Increased levels of nitrate and surfactant protein A nitration in the pulmonary edema fluid of patients with acute lung injury. Am J Respir Crit Care Med 163: 166-172, 2001.
274. Zischka H, Weber G, Weber PJ, Posch A, Braun RJ, Buhringer D, Schneider U, Nissum M, Meitinger T, Ueffing M, and Eckerskorn C. Improved proteome analysis of Saccharommyces cerevisiae mitochondria by free-flow electrophoresis. Proteomics 3: 906-916, 2003.